Thyroid Cancer

Thyroid Cancer is cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope.

What is Thyroid Cancer?

Thyroid cancer is a type of cancer involving unregulated cell growth in the thyroid gland, which is located at the base of the neck. It is a rare type of cancer, accounting for approximately 1% of all people diagnosed with cancer.

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Microwave ablation offers a promising treatment option for multifocal papillary thyroid cancer

In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published today in Radiology, a journal of the Radiological Society of North America.

2 Apr 2024

Understanding the genetics behind thyroid cancer to prevent unnecessary invasive treatments

Researchers at the University of Colorado School of Medicine are hopeful new research could prevent up to 130,000 unneeded fine-needle aspiration (FNA) biopsies of thyroid nodules and subsequent surgeries each year in the United States by better understanding the genetic risk associated with thyroid cancer.

1 Apr 2024

Tuberculosis linked to increased risk of cancer, study finds

A population-wide observational study to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynaecological and colorectal cancers.

1 Apr 2024

Research from NY highlights pollution as a key factor in rising cancer rates among youth

Cancer incidence trends among adults in the New York State (NYS) and associations with common population-level exposures.

28 Mar 2024

Low-risk differentiated thyroid cancer patients in the U. S. experience lower rates of mortality

A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low.

22 Mar 2024

Inherited genetic factors may predict elevated risk of new cancers among childhood cancer survivors

Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors, according to a study led by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health.

7 Mar 2024

Genetic blueprint revealed: New insights into thyroid cancer's resistance and transformation

A new research perspective was published in Oncotarget's Volume 15 on January 24, 2024, entitled, "Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation."

30 Jan 2024

Promising PET scanner tool developed for rare medullary thyroid cancer

A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine.

11 Jan 2024

Research discovers fibronectin's role in BRAF-mutant thyroid cancer resistance

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene -; a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.

10 Jan 2024

HPV infection linked to doubled risk of thyroid cancer

A study in Taiwan involving 3,062 thyroid cancer patients and 9,186 controls finds that HPV infection more than doubles the risk of developing thyroid cancer, providing the first evidence of a carcinogen for this common endocrine cancer.

4 Jan 2024

Socioeconomic status correlated with thyroid cancer diagnosis and death probability

The incidence of thyroid cancer in São Paulo State, part of Brazil's relatively developed Southeast region, varies considerably according to socioeconomic status (education, poverty, wealth, income, segregation, mobility, and access to resources and services) and access to screening, but is highest in higher-income areas and the state capital.

31 Oct 2023

PFAS chemicals in water and consumer goods linked to rising thyroid cancer rates

Study published in eBioMedicine reveals that exposure to certain per- and polyfluoroalkyl substances (PFAS) significantly increases the risk of thyroid cancer. Among various PFAS, linear PFOS and its derivatives are identified as potent contributors, emphasizing the need for large-scale studies and highlighting the risks of contaminated drinking water.

25 Oct 2023

Study shows high prevalence of thyroid cancer among transgender female veterans

A new study by UC Davis Health endocrinology researchers has shown a high prevalence of thyroid cancer among transgender female veterans.

25 Oct 2023

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Researchers from The Hospital for Sick Children (SickKids), the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) have demonstrated that by analyzing patients' blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent life-time risk of developing cancer.

24 Oct 2023

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

22 Oct 2023

Researchers develop AI-based tool for estimating cancer patient's chances for survival

Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient's chances for surviving long term, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2023.

20 Oct 2023

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not make a difference in outcomes for treating patients with an advanced form of thyroid cancer that develops from thyroid follicular cells called differentiated thyroid cancer (DTC).

1 Sep 2023

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Researchers examined the association between moderate alcohol intake and specific cancer risks.

21 Aug 2023

Thyroid Cancer

Overview

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Latest Thyroid Cancer News and Research

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Microwave ablation offers a promising treatment option for multifocal papillary thyroid cancer

Understanding the genetics behind thyroid cancer to prevent unnecessary invasive treatments

Tuberculosis linked to increased risk of cancer, study finds

Research from NY highlights pollution as a key factor in rising cancer rates among youth

Low-risk differentiated thyroid cancer patients in the U. S. experience lower rates of mortality

Inherited genetic factors may predict elevated risk of new cancers among childhood cancer survivors

Genetic blueprint revealed: New insights into thyroid cancer's resistance and transformation

Promising PET scanner tool developed for rare medullary thyroid cancer

Research discovers fibronectin's role in BRAF-mutant thyroid cancer resistance

HPV infection linked to doubled risk of thyroid cancer

Socioeconomic status correlated with thyroid cancer diagnosis and death probability

PFAS chemicals in water and consumer goods linked to rising thyroid cancer rates

Study shows high prevalence of thyroid cancer among transgender female veterans

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Researchers develop AI-based tool for estimating cancer patient's chances for survival

Everyday chemicals linked to increased cancer risk, especially in women

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Thyroid Cancer

Overview

Latest Thyroid Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in